Table 1.
Demographic and Pre-treatment Characteristics
| Variable | Total N = 142 |
DCS+CBT N = 70 |
Placebo+CBT N = 72 |
Inferential Statistics |
|---|---|---|---|---|
| Age Mean (SD) | 12.79 (2.99) | 13.05 (2.93) | 12.54 (3.04) |
F(1, 139) = 1.03, p = .31 |
| Gender (% Female) | 53.5% | 60.0% | 47.2% | χ2 (1) = 2.33, p = .127 |
| Race/Ethnicity (% Caucasian) |
88.7% | 87.1% | 90.3% | χ2 (1) = 0.35, p = .555 |
| Mean Comorbidities (SD) | 2.12 (2.49) | 2.09 (2.09) | 2.15 (2.85) |
F(1, 140) = 0.02, p = .902 |
| Previous Comorbidities | ||||
| Depression | 20.4% | 22.9% | 18.1% | χ2 (1) = 0.50, p = .478 |
| Any Anxiety Disorder | 43.0% | 42.9% | 43.1% | χ2 (1) = 0.01, p = .981 |
| Any Tic Disorder | 13.6% | 11.6% | 15.5% | χ2 (1) = 0.45, p = .501 |
| Current Comorbidities | ||||
| Depression | 14.9% | 15.9% | 13.9% | χ2 (1) = 0.12, p = .732 |
| Any Anxiety Disorder | 36.7% | 37.7% | 35.7% | χ2 (1) = 0.06, p = .810 |
| Any TIC Disorder | 9.2% | 7.2% | 11.1% | χ2 (1) = 0.63, p = .428 |
| CYBOCS | 25.27 (5.98) | 26.24 (6.01) | 24.33 (5.85) | F(1, 139) = 3.67, p = .058 |
| CYBOCS-Item 11 | 1.13 (1.03) | 1.13 (1.10) | 1.13 (0.96) | F (1, 139) = 0.01, p = .955) |
| Family Accommodation | 15.09 (8.79) | 15.17 (8.75) | 15.03 (8.88) | F (1, 139) = .01, p = .922 |
| CBCL-Externalizing | 8.54 (7.25) | 8.09 (6.90) | 8.97 (7.59) | F (1, 132) = 0.49, p = .485 |
| MASC total | 48.66 (21.12) | 53.00 (22.39) | 44.25 (18.92) | F (1, 129) = 5.83, p = .017 |
| COIS-Child | 14.28 (10.26) | 14.63 (10.58) | 13.94 (9.99) | F (1, 129) = 0.15, p = .701 |
| TASCC total | 3.16 (.57) | 3.17 (.52) | 3.15 (.61) | F (1, 127) = 0.08, p = .779 |
| CDRS | 26.64 (9.13) | 27.56 (10.21) | 25.76 (7.91) |
F (1, 136) = 1.35, p = .218 |